| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2021 | SILVER LAKE RESEARCH CORPORATION | 1300 W OPTICAL DR | IRWINDALE | CA | 91702-3284 | LOS ANGELES | USA | R61HL154094 | A Rapid and Inexpensive Point-of-Care Test for Beta-Thalassemia Carriers | 000 | 2 | NIH | 12/8/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $0 ) |
| | 2022 | 2021 | SILVER LAKE RESEARCH CORPORATION | 1300 WEST OPTICAL DR STE 300 | AZUSA | CA | 91702-3284 | LOS ANGELES | USA | R61HL154094 | A Rapid and Inexpensive Point-of-Care Test for Beta-Thalassemia Carriers | 000 | 2 | NIH | 3/11/2022 | $0 |
| | 2022 | 2021 | SILVER LAKE RESEARCH CORPORATION | 1300 WEST OPTICAL DR STE 300 | AZUSA | CA | 91702-3284 | LOS ANGELES | USA | R61HL154094 | A Rapid and Inexpensive Point-of-Care Test for Beta-Thalassemia Carriers | 001 | 2 | NIH | 4/26/2022 | $0 |
| | 2022 | 2021 | SILVER LAKE RESEARCH CORPORATION | 1300 WEST OPTICAL DR STE 300 | AZUSA | CA | 91702-3284 | LOS ANGELES | USA | R61HL154094 | A Rapid and Inexpensive Point-of-Care Test for Beta-Thalassemia Carriers | 002 | 2 | NIH | 5/3/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $345,189 ) |
| | 2021 | 2021 | SILVER LAKE RESEARCH CORPORATION | 1300 WEST OPTICAL DR STE 300 | AZUSA | CA | 91702-3284 | LOS ANGELES | USA | R61HL154094 | A Rapid and Inexpensive Point-of-Care Test for Beta-Thalassemia Carriers | 000 | 2 | NIH | 9/20/2021 | $345,189 |
|
| Issue Date FY: 2020 ( Subtotal = $348,500 ) |
| | 2020 | 2020 | SILVER LAKE RESEARCH CORPORATION | 1300 WEST OPTICAL DR STE 300 | AZUSA | CA | 91702-3284 | LOS ANGELES | USA | R61HL154094 | A Rapid and Inexpensive Point-of-Care Test for Beta-Thalassemia Carriers | 000 | 1 | NIH | 8/10/2020 | $348,500 |
| | 2020 | 2018 | SILVER LAKE RESEARCH CORPORATION | 1300 WEST OPTICAL DR STE 300 | AZUSA | CA | 91702-3284 | LOS ANGELES | USA | R42AI108029 | Rapid Immunodiagnosis of Drug-Resistant Bacterial Pathogens | 000 | 5 | NIH | 6/29/2020 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $975,121 ) |
| | 2018 | 2018 | SILVER LAKE RESEARCH CORPORATION | 1300 WEST OPTICAL DR STE 300 | AZUSA | CA | 91702-3284 | LOS ANGELES | USA | R42AI108029 | Rapid Immunodiagnosis of Drug-Resistant Bacterial Pathogens | 001 | 5 | NIH | 7/25/2018 | $975,121 |
| | 2018 | 2017 | SILVER LAKE RESEARCH CORPORATION | 1300 WEST OPTICAL DR STE 300 | AZUSA | CA | 91702-3284 | LOS ANGELES | USA | R42AI108029 | Rapid Immunodiagnosis of Drug-Resistant Bacterial Pathogens | 000 | 4 | NIH | 7/20/2018 | $0 |
| | 2018 | 2017 | SILVER LAKE RESEARCH CORPORATION | 1300 WEST OPTICAL DR STE 300 | AZUSA | CA | 91702-3284 | LOS ANGELES | USA | R44HL123670 | Rapid LFIA blood test for SCD using highly specific monoclonal antibodies | 000 | 4 | NIH | 8/24/2018 | $0 |
| | 2018 | 2016 | SILVER LAKE RESEARCH CORPORATION | 1300 WEST OPTICAL DR STE 300 | AZUSA | CA | 91702-3284 | LOS ANGELES | USA | R43DK106944 | Development of Faster, Lower-Cost, High-Sensitivity Immunoassay for Specific Determination of Glucagon Using EAP-derived Monoclonal Antibodies | 000 | 2 | NIH | 6/15/2018 | $0 |
| | 2018 | 2015 | SILVER LAKE RESEARCH CORPORATION | 1300 WEST OPTICAL DR STE 300 | AZUSA | CA | 91702-3284 | LOS ANGELES | USA | R41AI108029 | Rapid Immunodiagnosis of Drug-Resistant Bacterial Pathogens | 000 | 2 | NIH | 8/14/2018 | $0 |
| | 2018 | 2015 | SILVER LAKE RESEARCH CORPORATION | 1300 WEST OPTICAL DR STE 300 | AZUSA | CA | 91702-3284 | LOS ANGELES | USA | R43HL123670 | Rapid LFIA blood test for SCD using highly specific monoclonal antibodies | 000 | 2 | NIH | 7/24/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $1,489,678 ) |
| | 2017 | 2017 | SILVER LAKE RESEARCH CORPORATION | 1300 WEST OPTICAL DR STE 300 | AZUSA | CA | 91702-3284 | LOS ANGELES | USA | R44HL123670 | Rapid LFIA blood test for SCD using highly specific monoclonal antibodies | 000 | 4 | NIH | 7/26/2017 | $500,000 |
| | 2017 | 2017 | SILVER LAKE RESEARCH CORPORATION | 1300 WEST OPTICAL DR STE 300 | AZUSA | CA | 91702-3284 | LOS ANGELES | USA | R42AI108029 | Rapid Immunodiagnosis of Drug-Resistant Bacterial Pathogens | 000 | 4 | NIH | 7/20/2017 | $989,678 |
|
| Issue Date FY: 2016 ( Subtotal = $1,714,659 ) |
| | 2016 | 2016 | SILVER LAKE RESEARCH CORPORATION | 911 SOUTH PRIMROSE AVENUE | MONROVIA | CA | 91016 | LOS ANGELES | USA | R42AI108029 | Rapid Immunodiagnosis of Drug-Resistant Bacterial Pathogens | 000 | 3 | NIH | 7/25/2016 | $994,558 |
| | 2016 | 2016 | SILVER LAKE RESEARCH CORPORATION | 911 SOUTH PRIMROSE AVENUE | MONROVIA | CA | 91016 | LOS ANGELES | USA | R43DK106944 | Development of Faster, Lower-Cost, High-Sensitivity Immunoassay for Specific Determination of Glucagon Using EAP-derived Monoclonal Antibodies | 000 | 2 | NIH | 7/29/2016 | $220,101 |
| | 2016 | 2016 | SILVER LAKE RESEARCH CORPORATION | 911 SOUTH PRIMROSE AVENUE | MONROVIA | CA | 91016 | LOS ANGELES | USA | R44HL123670 | Rapid LFIA blood test for SCD using highly specific monoclonal antibodies | 000 | 3 | NIH | 8/22/2016 | $500,000 |
| | 2016 | 2015 | SILVER LAKE RESEARCH CORPORATION | 911 SOUTH PRIMROSE AVENUE | MONROVIA | CA | 91016 | LOS ANGELES | USA | R41AI108029 | Rapid Immunodiagnosis of Drug-Resistant Bacterial Pathogens | 000 | 2 | NIH | 7/25/2016 | $0 |
|
| Issue Date FY: 2015 ( Subtotal = $744,989 ) |
| | 2015 | 2015 | SILVER LAKE RESEARCH CORPORATION | 911 SOUTH PRIMROSE AVENUE | MONROVIA | CA | 91016 | LOS ANGELES | USA | R41AI108029 | Rapid Immunodiagnosis of Drug-Resistant Bacterial Pathogens | 000 | 2 | NIH | 3/11/2015 | $300,000 |
| | 2015 | 2015 | SILVER LAKE RESEARCH CORPORATION | 911 SOUTH PRIMROSE AVENUE | MONROVIA | CA | 91016 | LOS ANGELES | USA | R43HL123670 | Rapid LFIA blood test for SCD using highly specific monoclonal antibodies | 000 | 2 | NIH | 6/9/2015 | $221,502 |
| | 2015 | 2015 | SILVER LAKE RESEARCH CORPORATION | 911 SOUTH PRIMROSE AVENUE | MONROVIA | CA | 91016 | LOS ANGELES | USA | R43DK106944 | Development of Faster, Lower-Cost, High-Sensitivity Immunoassay for Specific Determination of Glucagon Using EAP-derived Monoclonal Antibodies | 000 | 1 | NIH | 7/7/2015 | $223,487 |
|
| Issue Date FY: 2014 ( Subtotal = $521,510 ) |
| | 2014 | 2014 | SILVER LAKE RESEARCH CORPORATION | 911 SOUTH PRIMROSE AVENUE | MONROVIA | CA | 91016 | LOS ANGELES | USA | R43HL123670 | Rapid LFIA blood test for SCD using highly specific monoclonal antibodies | 000 | 1 | NIH | 8/1/2014 | $221,510 |
| | 2014 | 2014 | SILVER LAKE RESEARCH CORPORATION | 911 SOUTH PRIMROSE AVENUE | MONROVIA | CA | 91016 | LOS ANGELES | USA | R41AI108029 | Rapid Immunodiagnosis of Drug-Resistant Bacterial Pathogens | 000 | 1 | NIH | 4/8/2014 | $300,000 |
|
| Issue Date FY: 2012 ( Subtotal = $507,709 ) |
| | 2012 | 2012 | SILVER LAKE RESEARCH CORPORATION | 911 SOUTH PRIMROSE AVENUE | MONROVIA | CA | 91016 | LOS ANGELES | USA | R44DK085767 | RAPID POINT-OF-CARE TEST TO DETECT BACTERIURIA & CONFIRM URINARY TRACT INFECTION | 000 | 3 | NIH | 7/19/2012 | $507,709 |
|
| Issue Date FY: 2011 ( Subtotal = $492,291 ) |
| | 2011 | 2011 | SILVER LAKE RESEARCH CORPORATION | 911 SOUTH PRIMROSE AVENUE | MONROVIA | CA | 91016 | LOS ANGELES | USA | R44DK085767 | RAPID POINT-OF-CARE TEST TO DETECT BACTERIURIA & CONFIRM URINARY TRACT INFECTION | 000 | 2 | NIH | 6/30/2011 | $492,291 |
| | 2011 | 2011 | SILVER LAKE RESEARCH CORPORATION | 911 SOUTH PRIMROSE AVENUE | MONROVIA | CA | 91016 | LOS ANGELES | USA | R44DK085767 | RAPID POINT-OF-CARE TEST TO DETECT BACTERIURIA & CONFIRM URINARY TRACT INFECTION | 001 | 2 | NIH | 7/11/2011 | -$492,291 |
| | 2011 | 2011 | SILVER LAKE RESEARCH CORPORATION | 911 SOUTH PRIMROSE AVENUE | MONROVIA | CA | 91016 | LOS ANGELES | USA | R44DK085767 | RAPID POINT-OF-CARE TEST TO DETECT BACTERIURIA & CONFIRM URINARY TRACT INFECTION | 001 | 2 | NIH | 7/11/2011 | $492,291 |
|
| Issue Date FY: 2010 ( Subtotal = $100,000 ) |
| | 2010 | 2010 | SILVER LAKE RESEARCH CORPORATION | 911 SOUTH PRIMROSE AVENUE | MONROVIA | CA | 91016 | LOS ANGELES | USA | R43DK085767 | RAPID POINT-OF-CARE TEST KIT FOR THE DETECTION OF BACTERIURIA CALIBRATED FOR IMME | 000 | 1 | NIH | 2/8/2010 | $100,000 |
|
|
